GSK

GSK Sells $1bn Discounted Stake In Spin-Off Haleon

British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about £804 million...

Haleon First Quarter Profit Misses Analyst Expectations

Haleon, the world's biggest standalone consumer health business, has reported first-quarter profit below analyst expectations.

Haleon Forecasting 4% To 6% Revenue Growth this Year

Haleon, the world's biggest standalone consumer health business, has forecast 4% to 6% organic revenue growth in 2023.

Consumer Health Firm Haleon Posts 16.1% Jump In Quarterly Sales

Haleon, the former consumer health arm of GSK, has reported a 16.1% increase in third-quarter reported revenue as it raised prices, and lifted its sales ou...

Haleon Sees Revenue Up 13.4% In First Half

British consumer healthcare company Haleon, which GSK recently officially spun off, has reported revenue growth of 13.4% (up 11.6% in t), to £5.2 bil...

Haleon Posts Revenue Growth In First Half

British consumer healthcare company Haleon, which GSK recently officially spun off, has posted a trading update for the six months ended 30 June 2022.

GSK Announces Board And Committee Changes

Global biopharma company GSK has announced a number of changes to its board and committees, which are set to take effect immediately following the demerger...

GSK Spins Off Haleon In Biggest European Listing For A Decade

GSK has officially spun off its consumer health business, Haleon, in the biggest listing in Europe for more than a decade.

Subscribe Today

Subscribe now

Enjoy unlimited digital access for 30 days

Claim this offer

Enjoy unlimited digital access for 30 days

Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today

Subscribe now

Enjoy unlimited digital access for 30 days

Claim this offer

Get the app today!

GSK

GSK Sells $1bn Discounted Stake In Spin-Off Haleon

Haleon First Quarter Profit Misses Analyst Expectations

Haleon Forecasting 4% To 6% Revenue Growth this Year

Consumer Health Firm Haleon Posts 16.1% Jump In Quarterly Sales

Haleon Sees Revenue Up 13.4% In First Half

Haleon Posts Revenue Growth In First Half

GSK Announces Board And Committee Changes

GSK Spins Off Haleon In Biggest European Listing For A Decade

GSK Spins Off Consumer Health Business Worth Up To $57bn

Pfizer Set To Exit GSK's Consumer Health Arm After Spin-Off

GSK Says Consumer Arm Spin-Off 'On Track', Stands By Forecasts

GSK To Float Consumer Arm In July Despite Volatile Markets

Unilever Warns Of High Inflation, Rules Out Major Acquisitions

GSK Sees Sales Growth In 2022 After Beating Quarterly Forecasts

Unilever's Offer For GSK Raises Doubts, Questions Over Strategy